artemisinin-based combination therapy

GPTKB entity

Statements (61)
Predicate Object
gptkbp:instance_of gptkb:drug
gptkbp:bfsLayer 6
gptkbp:bfsParent gptkb:Plasmodium_falciparum
gptkb:Plasmodium_knowlesi
gptkb:Plasmodium_ovale
gptkbp:appointed_by injections
oral tablets
gptkbp:can_be_used_with non-artemisinin drugs
gptkbp:caused_by hypersensitivity reactions
QT prolongation
gptkbp:collaborated_with research institutions
gptkbp:developed_by gptkb:artemisinin
gptkbp:first_introduced 1990s
gptkbp:formulation co-packaged therapies
fixed-dose combinations
https://www.w3.org/2000/01/rdf-schema#label artemisinin-based combination therapy
gptkbp:improves treatment adherence
gptkbp:includes gptkb:artemisinin
gptkb:dihydroartemisinin
gptkb:lumefantrine
gptkb:mefloquine
gptkb:piperaquine
gptkbp:is_analyzed_in cost-effectiveness
gptkbp:is_associated_with reduced transmission
gptkbp:is_challenged_by drug resistance
gptkbp:is_discussed_in gptkb:academic_journal
scientific conferences
gptkbp:is_effective_against gptkb:Plasmodium_falciparum
gptkbp:is_evaluated_by gptkb:municipality
safety and efficacy
public health studies
gptkbp:is_influenced_by drug policy changes
gptkbp:is_informed_by epidemiological data
gptkbp:is_linked_to improved patient outcomes
gptkbp:is_monitored_by cardiac effects
gptkbp:is_part_of treatment protocols
treatment regimens
malaria control strategies
global malaria eradication efforts
gptkbp:is_promoted_by healthcare providers
public health campaigns
gptkbp:is_studied_in resistance patterns
gptkbp:is_subject_to clinical trials
regulatory approvals
gptkbp:is_supported_by research funding
international health organizations
gptkbp:is_used_for treating malaria
gptkbp:is_used_in gptkb:Southeast_Asia
gptkb:sub-Saharan_Africa
tropical regions
gptkbp:is_utilized_in treatment guidelines
gptkbp:reduces malaria mortality
gptkbp:requires diagnosis of malaria
gptkbp:side_effect dizziness
headache
nausea
vomiting
gptkbp:suitable_for gptkb:World_Health_Organization
gptkb:CDC
monotherapy
uncomplicated malaria